Welcome to Finextra. We use cookies to help us to deliver our services. We'll assume you're ok with this, but you may change your preferences at our Cookie Centre. Please read our Privacy Policy.
Sequels are never as good as the original. For the second time in ten years I am drawn to yet another media frenzy concerning the apparent premature death of EMV. Really? The story surrounds a hardw...